Prime Takes

Short essays on assorted topics from the Prime Team

Prime Trends – Consumption: Our newest smallcase portfolio

What does your typical day look like? You wake up, have a cup of coffee or tea. There’s breakfast to have, lunch to prepare, laundry to do, spend the day at work, with a well-earned sleep at the end. 

But that’s just the routine! There’s so much more you do in the day – stepping out to a nice lunch with colleagues, browsing through Amazon or Flipkart and filling up that shopping basket or then going out to the mall and doing the same. Swiggy or Zomato come in handy when you’re too tired to get dinner ready. Your commute is made bearable listening to music or podcasts on your phone or the perfect car sound system. Weekends are spent at the movies, at dinner maybe, or lazing at home with your big-screen TV. Or perhaps driving down in your comfortable SUV to a short weekend getaway once in a while! 

This is your story. This is the NEW consumption story. Aside from the routine goods we all consume to live and survive, life has now become more about aspirations and experiences.  Call it the YOLO effect or upgrading your lifestyle, you are now revving up the New Consumption story in India. 

Prime Trends – Consumption: Our newest smallcase portfolio

Our newest smallcase portfolio – Prime Trends – Consumption is built precisely on this consumption theme. 

Broadly, the following four factors form the basis for our investment thesis: 

  • Discretionary spending pick-up: The general thesis is that the average income levels of the population has crossed the threshold that takes care of the basics and incremental income will now go towards discretionary consumption.
  • State-wise trends indicate an acceleration in spends across the spectrum: Some of the more developed states, which have crossed well beyond the national per-capita average, have become the bedrock of modern retail and discretionary consumption. Meanwhile, currently poorer states can see consumption picking up as they progress in development thanks to improved infrastructure, shift towards manufacturing and higher labour force participation.
  • Growing middle-class to spur aspirational spending: A World Economic Forum study says that the number of middle-income households is likely to increase from 21% of population in 2018 to just over 40% of the population by 2030. Easier access to credit and social media, along with e-commerce, have also become enablers of consumption. All point to a healthy growth rate, far higher than nominal growth rate, for companies that can successfully address the growing consumption needs.
  •  Scope in individual regions: The large size of our economy and the economic output of each geography offers scalable opportunities for businesses. It isn’t necessary for a country-wide presence for companies to scale up; the sheer size of each region offers ample scope even for regional players.

Current market conditions are also lining up for a well-timed entry. There is, of course, the broader market correction that we’re seeing. Even without this, the shine has been rubbed off the consumption story in recent times. The Covid and post-Covid periods have caused fluctuations in the demand (and input costs) environment and this is reflecting in quarterly earnings numbers, and consequently in stock prices. Several higher-priced consumer plays are now available at attractive valuations, providing a good window of investment opportunity. The long-term consumption story, therefore, looks even better now!

So, if your spending is going to charge the economy and the consumption theme, there is a way to also benefit from it!

30% Crypto tax

The 30% Crypto tax is the Indian government at its passive aggressive best (or worst, depending on your view point).

The text of this tax law coupled with what the finance minister said in the post-budget interview leads me to think that the government holds the crypto ecosystem in absolute disdain.

The crypto exchange promoters are welcoming this move as a recognition bestowed upon them. Obviously, they are choosing to see the slim silver lining.

30% Crypto tax

Truth is this is just one jaw of the vice that is going to be applied on the crypto industry.

The other jaw will likely be when the crypto bill is introduced regulating these exchanges with stipulations such as these:

1. Requirements for KYC registration (not just collecting PAN but registering with KRAs)
2. Limits on the range of crypto assets that can be offered for trade (likely by coin market cap initially and with regulatory approval then on)
3. Possibly, placing qualification limits on investors allowed to invest in crypto (bringing to bear the ‘accredited investors’ concept that SEBI is working on)
4. Severe curbs on how they can be marketed (no celebrities, for example)

In essence, the government would do everything short of banning to ensure that the growth of this industry is significantly tempered.

Why would the government do this? Simple:

1. India is not a big crypto mining country – we don’t have the power capacity to spare.
2. That means most of the crypto assets are ‘imported’.
3. Which means flight of capital and a potential current account problem for the central bank and the government

India already is struggling with gold – another non-productive, imported asset that causes balance of payment issues. Why would they encourage creation of another?

Value of independence – a response to our critics

A recent ET Wealth study done jointly with us, had many of our distributor and advisor friends lash out at us on social media. The same happened some months ago when we took a firm call on Franklin funds. We thought we should not react but since this appears to be repeating, we decided to ‘respond’. 

We have several ‘buy’ calls on funds. No distributor/advisor criticizes us for wrong judgement there. Whenever we give ‘sell’ calls, we are hit out in the social media (without naming us of course – they are gentlemen) as being ‘immature’ ‘rash’ and that we ‘need schooling’, ‘we do this for a hobby’  or ‘performance alone does not matter’ etc. These comments are never from investors (they give us more constructive feedback, thankfully). They come from doyens in the advisory industry whom we respect and from whom we learn, along with several respectable distributors. And many are but good friends in Chennai! It’s a small city here folks.

To these doyens and distributor friends, we wish to say –  we are open to learning. We welcome criticism. But we prefer them to be issue-based and factual. A general dig about our ‘testing labs’ doesn’t help us improve, you know! 

Value of independence - a response to our critics

So, here’s the thing: 

When we gave a ‘sell’ call on Franklin fund house, it was only partly based on the performance – our detailed note had it (not our problem that the media took excerpts).  It was a judgement call on how a fund house that put investors through painful times can be depended upon again. It is our view and we stated it clearly. Why does it upset distributors? Please feel free to counter it with a rebuttal based on facts and logic. 

When we wrote on HDFC Top 100 or ABSL Frontline Equity a year ago on why we prefer index funds to these large caps it was based on sound evidence of exceedingly inconsistent performance. It remains the same. 

For those who question us on our testing labs, we wish to make two points: One, our process and our thought process: We like to follow a process rather than just tell our customers ‘X fund manager is a good guy. We trust him. He has conviction in his calls’. That is not our way. 

We respect all fund managers and their difficult task. But to us, performance matters and consistency in performance matters the most, however small or big an AMC or fund manager. Our numbers time and again show that consistency pays off in the long run. Our ‘testing labs’ have enough ‘metrics’ to show us ‘steady relative underperformance or outperformance’. 

Yes, we do go beyond numbers to the ‘prudent portfolio construction’ that someone asked us to measure. Every fund’s portfolio has a story to tell and means to be prudent. One can decide not to tolerate the portfolio underperformance, or one can give a narrative of conviction and decide to wait. Where it is not clear, we do hear what the fund manager has to say. We recently did that for a midcap fund too! 

But in this qualitative second step, it boils down to what convinces us or the investor. And that becomes a subjective call.  That is where we take comfort in process. We take comfort in a fund manager sticking to his/her process but willing to make changes when the performance chain breaks. We think that is an important quality in fund management. Course correction shows willingness to change and improve. 

Instead, to ask an investor to wait it out because a fund cannot perform or will perform in spurts and go silent later is not quite convincing, is it? And for 3 years, 5 years? Does an investor need a fund manager and an advisor on top of it, to say this? He might as well throw a dart! 

Two, investor behaviour: There is little reason for an investor to tolerate prolonged underperformance simply because the odd year will give him the bounce back. Which year will that be? In Tamil, there is an adage: ‘thai pirandhaal vazhi pirakkum (come the harvesting Tamil month of thai in January, there will be a new path). A poor fellow asked ‘endha thai?’ (which January will it be?) The odds don’t favour an investor in the face of prolonged volatility and stark underperformance. 

 Our own study of several thousand customers in an earlier firm, tells us that investors who are long-term will not put up with poor performance beyond a year or two. 

Secondly, there is a HUGE difference between a young investor with a portfolio of a few lakhs and another with several crores. The latter is affected very little by underperformance in a couple of funds while the former does take an impact when his few thousands of SIP underperform. 

Besides, he/she now has a poor experience. He will not return. 

And pray, when they have better alternatives in MFs, what favour are we doing by asking him to stick to an underperformer? Is it tax? It is the investor who should be concerned, not the advisor/distributor. Please don’t take an investor to be a fool! Is it commission? In that case an investor should be even more concerned!

 For 20 years or so ‘the buy and hold’ mantra has stood investors (and distributors) in good stead (and still does). But that is meant to ride out the market volatility and the market underperformance – NOT FUND UNDERPERFORMANCE when a whole bunch of other funds manage their act! 

If investors did that 15 years ago, it was because they could not keep track of performance. It was too cumbersome to even switch funds! Any reason they should act the same now, when they can see their fund’s performance with a click and there are better and clearer alternatives? Even if that means simply an index fund? 

Besides, the 20-year argument is not going to help an investor who has, say, 7-12 years to accumulate enough returns for their children’s education, does it? Is 10 years too short a period to expect a fund to deliver?

And who are we – as advisors, researchers, or distributors to ask investors to put up with underperformance for no reason? Who are we to insist that an investor MUST hold THE SAME FUND for 20 years to see results? Who are we to bask in the past glory of an AMC’s 25 years track record when a 25-year-old doesn’t give two hoots about it? 

And how long are we going to say not holding ADAG stocks helped a fund in hindsight or not going near infra and real estate helped an AMC in 2008? Of course, it did help! Good for the investors. MOVE ON and show us what funds do NOW!!! 

It’s about time the investor’s ‘guides’ took a relook at changing investor preference, changing product line-up and changing ways to invest, track and review. Why are index funds a taboo in many distributors’ books, even today? 

And finally, our calls on funds are our views. We will stay accountable to investors who take them. Why does it bother so many of our distributor friends? After all, they have their own processes and outcome to share with their clients? 

Also, please be assured – we have our own ‘research game’ and we don’t need any ‘schooling’. We have our own track record of writing and educating investors through various forums including media. And we definitely have a track record of creating wealth for thousands of grateful investors across the country through our research and recommendations.

Gentlemen, you’re all welcome for a coffee session in our office if you want to know if we have ‘metrics’.  We will be happy to show you. The learning can be mutual! Avoid ‘virtual’ mudslinging and troll-like behaviour. Doesn’t do anybody any good. 

Let’s move on. It’s not 2001, its 2021! The investor is king not the manufacturer!!

Four books

After a flurry of book reviews earlier this year, I have gone largely silent on this count. Not that I became suddenly too busy or stopped reading books. Rather, I decided to go ahead and clear out some backlog that I had in my personal reading list. Here are brief notes about each of them – I hope one or more of these catch your fancy.

None of these books are particularly ‘PrimeInvestor’ topic – relating to personal finance or FinTech. Nevertheless, I thought I’ll share my thoughts on these books – 4 of them – in a brief note. Some of these books are quite popular, and all of them are worth your time, if the topic interests you.

“A Short History of Nearly Everything” by Bill Bryson

Although this book was neither short (running to more than 500 dense pages) nor about history in the traditional sense of the word, it made for a fascinating read. It does cover ‘nearly everything’ though – starting from the big bang and finishing up a few years after the millennium. The book gives a history of science and scientific discoveries across the spectrum – from cosmology (where it starts) through palaeontology, geology, and the modern physical sciences. There is a lot of stuff about the lives and quirks of scientists which can be occasionally distracting from the flow of the science in the book, but nevertheless quite engaging.

Buy A Short History Of Nearly Everything (Re-Issue) (Bryson) Book Online at  Low Prices in India | A Short History Of Nearly Everything (Re-Issue) ( Bryson) Reviews & Ratings - Amazon.in

People who went to school in the 80s (like myself) or even the 90s, will likely find out that a lot of stuff they learnt in school are outmoded now thanks to newer discoveries. The book is a good refresher on science for everyone. Non-science folks, especially, will find this book a good, friendly guide to the realms that they are likely not familiar with.

Link to book in Amazon (not an affiliate link)

“From Socrates to Sartre” by T Z Levine

This book, written in mid-80s, presents a survey of western philosophy from a historical perspective. There are 6 main sections covering individual philosophers through the ages – Plato, Descartes, Hume, Hegel, Marx, and Sartre. Not to say that these are the only philosophers or schools of thought covered – there are quite detailed accounts of Aristotle (obviously), Kant, Nietzsche, Wittgenstein, and more. The sections on Hegel and Marx are especially strong and relevant to this day. And, of course, existentialism, in a completely different sense, captures the personal ennui of modern existence. So, the book provides a macro perspective that can be helpful to make sense of our contemporary quotidian existence.

Buy From Socrates to Sartre: The Philosophic Quest Book Online at Low  Prices in India | From Socrates to Sartre: The Philosophic Quest Reviews &  Ratings - Amazon.in

The language is quite simple and the writing style fluid, which makes for fluent, if not easy, reading. You can expect to come out of the reading with a bird’s eye view of the western philosophical landscape, up until relatively recent times. Indian readers may be disappointed by the lack of any mention of oriental, leave alone Indian, philosophical thoughts and how they compare with the occident.

Link to book in Amazon (not an affiliate link)

“Godel, Escher, Bach – An Eternal Golden Braid” – Douglas Hofstadter

This is a book that I started reading in college, but never got around to finishing until recently. It’s a most remarkable book – even saying that it’s a work of staggering intelligence would be underselling it.

Bach was a genius composer from the 18th century. MC Escher was a graphic artist from early 20th century. Kurt Godel was a logician and mathematician from the same period as Escher. What the works and findings of these three have in common is the subject matter of this book. Using concepts such as recursion, strange loops, self-reference, and self-replication, the author spins a web of connections between the seemingly disparate fields of art, music, science, and mathematics. The chapter on Zen koans provides for a delightful excursion into the world of meanings and meaninglessness. The exposition of Godel’s famous incompleteness theorem is the most lucid and patiently developed among the handful of explanations I’ve read on the topic. The extrapolation of the concepts of recursion and replication into the world of cellular genetics is eye-opening.

Gödel, Escher, Bach: An Eternal Golden Braid: Douglas R. Hofstadter:  9780140055795: Amazon.com: Books

For those uninitiated into the music of Bach, this book will provide great motivation to get into it. And for those with a passing familiarity (like myself), it would likely take them into unexplored territories and provide great insights. For example, I discovered ‘Crab canon’ and this ingenious depiction and play of the piece on a mobius strip.

The later chapters on artificial intelligence provide a good grounding on the fundamental questions in the field, but can be underwhelming for those who have followed the developments in the area over the past four decades since this book was published (in the early 80s).

Overall, the book is not an easy read – although the author makes strenuous effort to keep it engaging with motivating dialogues that precede every chapter. The book runs into 750+ large format pages, and definitely not for casual reading. However, for those that commit and apply to get through it, there are rewards aplenty.

Link to book in Amazon (not an affiliate link)

“Seven Brief Lessons on Physics” – By Carlo Rovelli

After reading the Hofstadter’s tome, I definitely needed something smaller and this book let me go all the way to the other end of the spectrum in that aspect. ‘Seven brief lessons’ is almost a tenth of the size of GEB, coming in at 80 pages. But it makes for a thoughtful read nevertheless.

This book, published in 2015, brings readers up to speed (or up to 2015) on various advancements in physics. Covering topics like general relativity, quantum theory, quantum gravity, gravitational field, particle physics, and thermodynamics, it presents a bird’s eye view of what the current state of knowledge is in these disciplines. The language and style are masterful and easy to follow.

Buy Seven Brief Lessons on Physics Book Online at Low Prices in India | Seven  Brief Lessons on Physics Reviews & Ratings - Amazon.in

Of course, short 10-15 page essays on these topics hardly do justice to these vast areas of study, and leaves the reader wanting to know more. And that might precisely be the aim of the book.

The last ‘lesson’ of the book is a wonderful and reflective – almost meditative – essay that provides perspective on how human beings are situated in the vast cosmos and what our eternal quest has been.

Link to book in Amazon (not an affiliate link)

I chose these four books not as a group, but individually for different reasons. One of these books was recommended to me by a friend while I was reading the others.

But, I could easily see the recurring themes in all these books. No theory – be it physical or philosophical – is final. No finding is absolute. No ‘truth’ is unchallengeable. It is both humbling and invigorating at the same time.

The pursuit of knowledge embodied in each of these books is remarkably similar and provide a rather encompassing insight about humanity’s earnest endeavors over time. But this pursuit may never end, and our body of knowledge is likely to be ever ‘incomplete’.

Frivolous features

paytm money

You can tell when a platform marketplace is getting too crowded when useless, misleading ‘features’ get added on to the software in the quest for ‘differentiation’. I ran into a prime example of just such a thing when someone sent me a screenshot of a page from the Paytm Money app.

This page/screen is part of the SIP setup flow of the app. When an investor chooses a fund to set up a SIP, the app shows a calendar to choose a monthly date. So far, so good, and expected.

What is not quite expected is the extra ‘information’ provided in the calendar. Each date is accompanied by a percentage figure (see image). This number purports to show how a SIP on that date has performed relative to the other SIP dates.

That is, each date is accompanied by a percentage that tells you (per the explanation in the bottom of the screen) the outperformance (or underperformance) of an SIP done on that date compared to the average SIP performance for that fund over the past 1 year.

Wow! Right? Now, an investor can choose, for EACH fund they are investing in, the exact date that could maximize their returns!

But, of course, this is BS. For one, the sample size is ridiculously small – 12 data points for each date, and two, using the recent one-year performance for an equity fund for making long-term investment decisions is just plain wrong.

Mercifully, as useless and frivolous this feature is, it is unlikely to cause much harm to investors. As our recent researched article shows, it does not quite matter which date you choose for your equity fund SIP – the returns differential is minimal and entirely up to chance. So, just because you choose a ‘high-return’ date based on this data, it won’t dent your returns significantly.

But that doesn’t make for a good marketing tagline, does it? 🙂

OLD is GOLD for Music Stocks!

If you’ve been whiling away the hours listening to legends such as Lata Mangeshkar or Kishore Kumar, you’re not alone. And as you returned to yesteryear classics, so too have stock markets gone back to two companies that own the rights to these and thousands of songs. SAREGAMA India and TIPS Industries have seen their stocks hit new highs after 20 years. 

music stocks

Image Source : Saregama Website

SAREGAMA and TIPS own the rights for thousands of songs from the 90s. SAREGAMA owns the rights for over 1.3 lakh songs, TIPS owns rights for nearly 25,000 songs.

The two stocks have gained 10 times in the last 1 year!

So, why the sudden revival of old music? A few developments appear to have led this trend.

  • An increased demand for streaming music, thanks both to the explosion of such platforms and cheap data, and from the effect of the work-from-home development.
  • Legal developments that worked in favor of licensing rights of the music IP owners
  • Companies signing licensing deals with streaming platforms.

Quite apart from these, the fancy for these stocks could also be that markets were picking up on work-from-home beneficiaries! Please note that this is not a review or a recommendation on the industry or the stocks. This is simply a quick take to explain the trend in music stocks.

Music and video streaming platforms

Cheap data and high smartphone penetration are driving demand for music through streaming platforms. The music segment now contributes significantly to the total revenue for the Indian music recording industry. The demand for music also appears to have jumped as millions working from home turned to increased streaming. A survey conducted by Nielsen for Spotify concluded that audio-streaming apps are among the top five ways Indians discover new music.

The OTT music streaming segment is highly competitive with domestic music platforms like Saavn, Gaana & Hungama, as well as international streaming platforms like Apple music, Amazon Prime, Google Play, Spotify & others.

Internet broadcasting & copy right laws

Two, an interesting development on the legal side seems to be working in favor of these companies. The Spotify Vs Warner legal battle in India appears to be leading to favorable thinking in terms of rights and licensing requirements. 

The need for licensing agreements pursuant to an interim order by Bombay HC in a recent legal battle points to better pricing deals for IP right owners in future.

Music stocks – business boost

So, how has this helped Tips and Saregama? Well, they are licensing their IP rights on their song library to various platforms. The shift in the way people consume music as well as legal developments have helped companies combat the piracy and licensing issues that they struggled with in the past. This is helping them monetize their IP rights on a significantly larger scale. 

SAREGAMA, for example, has inked licensing deals with both domestic and global players including Facebook, Spotify, ShareChat, and Triller, as well as big platforms such as YouTube and Amazon Music

For SAREGAMA, licensing revenue has doubled in last 4 years from Rs. 138 crore in 2017 to Rs. 283 crore in FY2021. This jump comes even as the company reported a decline in revenue from Rs 544 crore in 2019 to Rs 442 crore in 2021. It now wants to invest Rs.200 crore for acquisition of new music over the next two to three years to capture 20% share of new music. 

Similarly, TIPS has inked licensing deals with Facebook, YouTube, ByteDance’s Resso, JioSaavn, and Amazon Music. The company, which is also the largest producer of Punjabi films, has initiated a demerger exercise to separate music and film businesses, suggesting that it sees enough promise in the music industry to let it stand alone.

Of course, how steadily these revenue sources can scale up for the companies bears watching.

Investing in Cryptocurrencies

Occasionally, we get questions at PrimeInvestor about investing in cryptocurrencies. Unsurprisingly, these questions arrive at a higher frequency when these currencies are trading higher and making rapid up-moves. As they are doing now. BitCoin is trading at higher than $56,000, more than 700% up in one year. And there is the new DogeCoin which has moved up 30x in just 4 months!

cryptocurrencies

At PrimeInvestor, we don’t cover these instruments from a content perspective, nor do we conduct research in them. Naturally, we do not recommend our customers/subscribers invest in any of them.

Why? For the following reasons:

  1. They are not regulated in India. The currency is not regulated by RBI (which actively frowns on them), and trading/investing in them is not regulated by SEBI. As such, these activities are to be done entirely at the risk of the investor, without any regulatory cover or oversight. We don’t cover such investment products.
  2. They are purely speculative – there is no tangible underlying asset – either a commodity or a business with cash flows – that drive the value of these instruments. They are purely driven by scarcity of a digital creation, and by supply and demand in the market.
  3. There is nothing to research – Reams and reams of documents have been written about cryptocurrencies, especially BitCoin, but most of them are about global central banks, inflation, and other economic indicators – signals that are used to predict (read: speculate) on the prices of these currencies. And their prices move due to things like a tweet from Elon Musk. These are not things that can be analysed or researched.

Just like the GME story from earlier this year (and ongoing), they are tempting, captivating narratives. But there is little in them beyond material for pleasant daydreams. When you wake up from these dreams, rest assured that PrimeInvestor will be there to guide you along a safer, steadier path to financial security and freedom.

Investing and watching India play cricket

I like to approach my investing with the same mindset that I approach watching India play cricket abroad. The keyword there is ‘abroad’.

See, when India plays abroad (and I mean the SENA countries – South Africa, England, New Zealand and Australia), my expectations are low. When they do better, I am elated, and when they lose, I don’t get too depressed.

watching cricket

I think watching our investment portfolio should be the same. Having realistic expectation means, a boom market (like now) makes us real happy, but a downturn does not faze us much. There is, let’s just say, downside containment of our disappointments 🙂

On the other hand, if we look at our portfolio like watching India play at home (like right now), we expect too much, every defeat is a an unexpected disaster, and a win feels like just ok.

Not good feelings; And makes us act rashly with our portfolio (like ‘resting’ Rohit Sharma :-/ )

How do we form the right expectations, you ask? Glad you did – please read this article from our archives – it’ll set you right!

Prof Scott Galloway

It’s not easy to impress me.

OK, that’s not true. I am not that hard to impress; so let me rephrase that.

It’s not easy to impress me a lot in a short time.

But that’s what happened today – I did not wake up on a Sunday morning looking to get impressed by the writings of a boomer professor in New York.

scott galloway

First, I watched a clip from Friday’s Bill Maher show (big fan) – one guy that spoke was very animated, and very impressive.

So I looked him up. Turns out he’s a NYU Stern professor, has written a few books, and has a blog.

I went to the blog, and started reading – and did not stop for a long time.

(links below)

The guy’s name is Prof. Scott Galloway, professor of Marketing at NYU Stern.

  1. He speaks well
  2. He writes fabulously
  3. He thinks broadly, and where appropriate, deeply
  4. His ideas resonate (with me), and
  5. He’s funny

I recommend you watch, read, and follow him as you find time.

The Youtube clip I saw today: https://www.youtube.com/watch?v=0H8AshEYrKw (Scott’s the guy who speaks con furioso)

Link to a blog article that you can start with: https://www.profgalloway.com/the-algebra-of-wealth

(This article is about the ‘algebra’ of wealth. He has written a book called ‘Algebra of Happiness’)

Happy reading!

Short take: What the SEBI’s circular on perpetual bonds means

SEBI’s recent circular on restrictions on both valuations and holdings of perpetual bonds by mutual funds has created a storm – not just among the fund manager community but all the way up to the Ministry of Finance.

The circular on perpetual bonds

The circular, broadly, states the following:

  • A mutual fund scheme cannot hold more than 5% of its assets in a perpetual bond issued by a single issuer. It cannot hold more than 10% of its total AUM in perpetual bonds in a single scheme.
  • No AMC can own more than 10% of the perpetual bond issued by an issuer.
  • Closed-end funds shall not invest in perpetual bonds.
  • The maturity of all perpetual bonds shall be treated as 100 years from the date of issuance of the bond for the purpose of valuation. Currently, MFs follow the call/put option date to value the yield.

The circular shall be made effective April 1, 2021.

What the circular means

The circular, if applied, shall mean 2 things:

  • Many funds will not be able to hold such a perpetual bond if their mandate restricts them. For eg. An ultra-short-term fund can’t meaningfully hold such an instrument.
  • Funds may need to revalue the bonds, and this can lead to mark-to-market losses as yields will be marked up if one considers the date of maturity as 10 years as opposed to 2-3 years.

Funds across the spectrum hold these funds. Banking & PSU debt funds, Low duration funds and balanced advantage/dynamic asset allocation funds are among the larger holders of this instrument. We will put out a more detailed report on fund holdings, if this circular remains.

It is noteworthy that, AMFI, in a response to this circular, has stated that the ‘100-year valuation’ will apply only if there is no traded value to the instrument. Now, this may provide some respite.

But here’s the bouncer. Media reports quote a communication from The Ministry of Finance (MoF) to SEBI – raising concerns about this proposal and the possible panic selling. It has also stated that perpetual bonds are used for bank’s capital needs and requested that the revised circular on valuation of perpetual bonds be withdrawn.

This being the case, we will wait for clarity on what is to happen before we write about it for you. As of now, restraining mutual funds from taking exposure to a highly risky category like perpetual bonds is a good move. However, the valuation norm, at an extreme 100 years, can cause impact on your NAVs. We’ll keep you posted.

Just doing it

When I read non-fiction books, I keep myself daily minimum targets to get through it in reasonable time – at least 100 pages a day, or in some tough reads, 50 pages a day.

With Phil Knight’s ‘Shoe Dog’,  I had to set for myself daily maximum reading targets – not more than 150 pages a day – so as to not let my other work suffer.

shoe dog

I could not, however, hold myself to the target – I finished the 400-page tome in a day and half flat. In one word, it’s ‘unputdownable’.

Chandra, my partner from FundsIndia, gave me the book 2 or 3 years ago and exhorted me to read it, and I’m ashamed that I just got around to it. Of course, as with the other books I am reading these days, I am wishing this book existed and that I read it, 15 or 20 years ago.

‘Shoe Dog’ chronicles the advent of Nike and the adventures of Phil Knight. It captures the period between 1962, when Phil first embarked on the journey (literally, actually), and 1980, when the company went IPO and Phil and his company, finally, made it.

It took 18 years to become an overnight success.

The tribulations that they went through during these years are, at the same time, totally pedestrian and incredibly arduous. From backstabbing partners to disloyal employees to relentless problems with bank and cash flow to lawsuits to fighting government bureaucracy – there is not a stripe of a problem they seem to have quite missed out on.

Through it all, they – Phil and his coterie of carefully assembled colleagues – persisted somehow – with a sleight of hand here, a slice of good fortune there, and honest to goodness hard work everywhere – to realize their vision and dreams.

It is a tale of dogged perseverance – and Phil alludes to it often in the book – the Oregon spirit. The state of Oregon is famous for the trail that it’s named after it – the Oregon trail. The path followed by migrating settlers who moved west in the early 19th century. The adage that accompanies the legend is that “The cowards never started and the weak died along the way. That leaves us, ladies and gentlemen. Us.”

And it’s not a dry business book either. As an autobiographical memoir, Phil opens up with extraordinary candour about his personal life as well. And it will be hard to be dry-eyed at the end of the book. And the quality of writing – the style and the narrative flow – is absolutely top-notch. It has all the flair and cultivated skill of a well-published author. The language is alternately poetic or dramatic as the narrative calls for. Not a dull moment.

I have a bit of a personal connection as well. Nike was my first “employer” – I interned at their sprawling headquarters in Beaverton, Oregon for two hot summer months in 1994. I caught a glimpse of Knight only once – as he walked by with his lunch tray in the cafeteria. By then, he was a god among men, at least in that campus. The road that led up to the main building from the outside world was called Bowerman drive (I used to cycle to the office – I would ride up this drive to the security block where they would hand out canteen coupons for people who biked to work). Back then, I had no idea about that name or the other names that the remaining lanes in the campus were called. 

I wish I did – the streets are all named after the people who were instrumental in the founding of Nike – all who are the protagonists of the story in the book.

My key takeaway from the book is this one thing, that is not said out loud in the pages. Phil Knight did not invent anything – sneakers were there before him, his partner invented waffle soles, people outside the company came up with the Air idea, and heck, even the name Nike was a colleague’s idea. But he had one thing – a passion for running and good shoes. Essentially, he had taste in footwear- he could tell bad shoes from good shoes. And he turned that love into a business and he never, ever let go.

‘Shoe Dog’ in Amazon

(Not an affiliate link)

Wealth in a Coffee Can

Few books have caught the interests of the Indian investing public as well as the book ‘Coffee Can Investing’ by Saurabh Mukherjea and others.

Fewer still investment methods have found a fan following as the stock picking process recommended in this book.

coffee can

Admittedly, I am a bit late to this party. Nevertheless, when I picked up the book and read through it, I could see why investors were enamored with it. The sub-title of the book captures the lure well – ‘The low-risk road to stupendous wealth’. Who would not find that enticing?

There are few problems with the book – more on that in a bit – but, the book is definitely a good read and worthy of recommendation. Please note that I am recommending the book, and not necessarily the investment process detailed in there. Please read and adapt it to your needs as you see fit. (Side note: Please don’t ask when PrimeInvestor is going to come up with a CC portfolio – we have our own philosophy and methods 🙂 )

The book’s premise is beguilingly simple – pick stocks that have a proven track record (of 10 years or more) of growing their revenues and have high return on capital employed (ROCE). The formula undergoes some changes when applied to financial services companies (looking at loan growth). But that is the simple step.

The tougher part may be to hold on to this portfolio without disrupting it for a period of 10 years. No profit booking in peak markets, no discarding of ‘losers’ – no activity in it at all. If you read the commentaries on this book, you will find many people taking issue with this hands-off approach. For example, when companies have governance issues as they often do, should we still keep holding? Or get out and find a new CC stock? That’s a tough call to make. 

But Saurabh and co present this method with conviction and by backing the conviction with data from the past. The book is replete with tables of returns from various such portfolios created at different points in time, all showing the merits of both the stock picking methods and the virtue of patient holding. 

The book also touches on some tangentially related topics along the way – about the Indian real estate market, on mutual fund expenses, investing in small-caps etc. Most of you, I think, will skim along these chapters, as I did. There is not much new there.

The book is a bit outdated though, in some respects. The authors keep mentioning that long term capital gains on equity investments is zero. We all know that since 2018, that has not been the case. Similarly, they advocate, in a specific case, investing in the dividend option of a mutual fund, which is also an anachronism for today’s world. Given that it’s been 3+ years since these changes came to effect, one would have thought that the book would have seen an edited version published.

And while they recommend mutual funds for small-cap investments, they provide little guidance on how to go about picking those funds (of course, PrimeInvestor subscribers have ready access to the top funds they should invest in).

Nevertheless, I liked this book for these reasons:

  1. The stress on the virtues of patience in  long-term investments – which is the achille’s heel of investors in general and Indian investors in particular.
  2. The commitment to a diversified portfolio – including other non-equity investments as well.
  3. The emphasis on looking at the costs of investing – like expense ratio, brokerages etc.

And, I have to mention a word about the writing style – it is top-notch. The book makes for an easy read – not necessarily a quick read, since there are many concepts to be digested on the way.

Readers of this book will come out with a better understanding of the Indian equity markets and will be more informed about stock-picking methods. And just those make the book a worthy read.

Coffee Can Investing in Amazon

(Not an affiliate link)

Hold On

You are being redirected to another page,
it may take a few seconds.
Login to your account
OR

Become a PrimeInvestor!

Get stock & mutual fund recommendations

Start registration

Start registration

OR
user icon
user icon
user icon

Terms & Conditions

A copy of the T&C has been sent to your email.

Last modified on February 18, 2025

This website www.primeinvestor.in (“Website”) is owned and operated by PrimeInvestor Financial Research Pvt. Ltd. (“RA”), a SEBI-registered Research Analyst with Registration No. INH200008653.

Through the Website, the RA allows clients to access research recommendations, research reports, and model portfolios, along with tools, personal finance products, and articles, on the payment of a subscription fee (“Research Services”). The terms ‘RA’ or ‘us’ or ‘we’ refer to PrimeInvestor Financial Research Pvt Ltd (SEBI RA Registration No INH200008653) who are the owners of this Website and offering the Research Services. The term ‘you’ and ‘client’ refers to the subscriber of the Services on the Website. The RA provides the Research Services subject to the notices, terms, and conditions set forth in these Terms. By accepting these Terms when you subscribe to the Research Services, you provide your consent to abide by these Terms.

Most Important Terms and Conditions (MITC)

[Forming part of the Terms and Conditions for providing research services]

  1. These terms and conditions, and consent thereon are for the research services provided by the Research Analyst (RA) and RA cannot execute/carry out any trade (purchase/sell transaction) on behalf of the client. Thus, the clients are advised not to permit RA to execute any trade on their behalf.
  2. The fee charged by RA to the client will be subject to the maximum amount prescribed by SEBI/ Research Analyst Administration and Supervisory Body (RAASB) from time to time (applicable only for Individual and HUF Clients).
    Note:
    • SEBI's current cap on fee is Rs 1,51,000/- per annum per family of client for all research services of the RA.
    • The fee limit does not include statutory charges.
    • The fee limits do not apply to a non-individual client / accredited investor.
  3. RA may charge fees in advance if agreed by the client. Such advance shall not exceed the period stipulated by SEBI; presently it is one quarter. In case of pre-mature termination of the RA services by either the client or the RA, the client shall be entitled to seek refund of proportionate fees only for the unexpired period.
  4. Fees to RA may be paid by the client through any of the specified modes like cheque, online bank transfer, UPI, etc. Cash payment is not allowed. Optionally the client can make payments through Centralized Fee Collection Mechanism (CeFCoM) managed by BSE Limited (i.e. currently recognized RAASB).
  5. The RA is required to abide by the applicable regulations/ circulars/ directions specified by SEBI and RAASB from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. The RA will endeavor to promptly inform the client of any conflict of interest that may affect the services being rendered to the client.
  6. Any assured/guaranteed/fixed returns schemes or any other schemes of similar nature are prohibited by law. No scheme of this nature shall be offered to the client by the RA.
  7. The RA cannot guarantee returns, profits, accuracy, or risk-free investments from the use of the RA's research services. All opinions, projections, estimates of the RA are based on the analysis of available data under certain assumptions as of the date of preparation/publication of research report.
  8. Any investment made based on recommendations in research reports are subject to market risks, and recommendations do not provide any assurance of returns. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report. Any reliance placed on the research report provided by the RA shall be as per the client's own judgement and assessment of the conclusions contained in the research report.
  9. The SEBI registration, Enlistment with RAASB, and NISM certification do not guarantee the performance of the RA or assure any returns to the client.
  10. For any grievances,
    • Step 1: the client should first contact the RA using the details on its website or following contact details:
      Customer care: [email protected]
      Grievance officer: [email protected], ATTN: Srikanth Meenakshi
      Compliance officer: [email protected], ATTN.: Bhavana Acharya
      Principal officer: [email protected], ATTN.: Vidya Bala
    • Step 2: If the resolution is unsatisfactory, the client can also lodge grievances through SEBI's SCORES platform at www.scores.sebi.gov.in
    • Step 3: The client may also consider the Online Dispute Resolution (ODR) through the Smart ODR portal at https://smartodr.in
  11. Clients are required to keep contact details, including email id and mobile number/s updated with the RA at all times.
  12. The RA shall never ask for the client’s login credentials and OTPs for the client’s Trading Account, Demat Account, and Bank Account. Never share such information with anyone including RA.

By browsing, viewing, using the Website and subscribing to the Research Services provided therein you consent to and agree to comply with these Terms and Conditions of subscription (“Terms”).

The RA reserves the right to change or modify the Website, the contents thereof and these Terms at any time. All modifications to these Terms & Conditions will be posted on the Website and will become effective immediately upon such posting. Changes once made will be communicated to the client. Continued use of the Website shall be construed as acceptance of the revisions to the Terms by conduct.

The following terms and conditions include but are not limited to minimum mandatory terms and conditions to clients as stipulated by SEBI.

1. Availing the research services

By accepting delivery of the research service, the client confirms that he/she has elected to subscribe to the research service of the RA at his/her sole discretion. The RA confirms that Research Services shall be rendered in accordance with the applicable provisions of the SEBI RA Regulations.

2. Obligations on RA

The RA shall be bound by the SEBI Act and all the applicable rules and regulations of SEBI, including the RA Regulations and relevant notifications of Government, as may be in force, from time to time.

3. Client Information and KYC

The client shall furnish all such details in full as may be required by the RA in its standard form with supporting details, if required, as may be made mandatory by Research Analyst Administration and Supervisory Body(RAASB)/SEBI from time to time. RA shall collect, store, upload and check KYC records of the clients with KYC Registration Agency (KRA) as specified by SEBI from time to time.

4. Standard Terms of Service

The consent of client shall be taken on the following understanding:

“I / We have read and understood the terms and conditions applicable to a research analyst as defined under regulation 2(1)(u) of the SEBI (Research Analyst) Regulations, 2014, including the fee structure.

I/We are subscribing to the research services for our own benefits and consumption, and any reliance placed on the research report provided by research analyst shall be as per our own judgement and assessment of the conclusions contained in the research report.

I/We understand that –

  1. Any investment made based on the recommendations in the research report are subject to market risk.
  2. Recommendations in the research report do not provide any assurance of returns.
  3. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report.”

The declaration of the RA is as follows:

  1. We are duly registered with SEBI as an RA pursuant to the SEBI (Research Analysts) Regulations, 2014 and our registration details are: registration no SEBI INH200008653, with registration date 19th August, 2021
  2. We have the registration and qualifications required to render the services contemplated under the RA Regulations, and the same are valid and subsisting;
  3. Research analyst services provided by us do not conflict with or violate any provision of law, rule or regulation, contract, or other instrument to which it is a party or to which any of its property is or may be subject;
  4. The maximum fee that may be charged by the RA is ₹1.51 lakhs per annum per family of client. Our current fee structure, the term and duration of our subscription for our Research Services, can be viewed on our website here: https://primeinvestor.in/prime-pricing
  5. The recommendations provided by us as part of the Research Services do not provide any assurance of returns.

5. Consideration and mode of payment

The client shall duly pay to the RA the agreed fees for the services that RA renders to the client and statutory charges, as applicable. Such fees and statutory charges shall be payable through the specified manner and mode(s)/ mechanism(s).

The payment of fees shall be through a mode that shows traceability of funds. Such modes include but are not limited to credit cards/debit cards/ UPI/ net banking or any other mode specified by SEBI from time to time. However, the fees shall not be in cash.

6. Risk factors

  1. Investments are subject to market risk. Investing or trading in financial products involves risk. Past performance of the recommendation is not an indication of future returns. Past performance of the RA is not an indicator of future performance. Past performance of the security is not an indication of future returns.
  2. There are no assurances or guarantees that the objectives of any investment in financial products will be achieved.
  3. The names of financial products mentioned herein do not in any manner indicate their prospects or returns. The performance in the equity may be adversely affected by the performance of individual companies, changes in the market place and industry specific and macro-economic factors.
  4. The performance of the investments/ products recommended by the RA are subject to a wide range of risks, including but not limited to: performance of the respective companies, changes in equity and debt market conditions, micro and macro factors and forces affecting equity and debt markets, general levels of interest rates and interest rate risk, credit risk, liquidity risk, reinvestment risk, economic slowdown, volatility & illiquidity of the stocks, risks associated with trading volumes, liquidity and settlement systems in equity and debt markets and/or such other circumstance beyond the control of the RA or any of its Associates.
  5. Other risk factors include that may affect the performance of the investments/ products recommended by the RA include but are not limited to economic policies, changes of Government and its policies, acts of God, acts of war, civil disturbance, sovereign action and /or such other acts/ circumstance beyond the control of the RA or any of its Associates.
  6. The recommendations provided by the RA as part of its Research Services may not be suitable to all categories of investors.
  7. The client should read all scheme and security related documents carefully before investing.
  8. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

7. Conflict of interest

The RA shall adhere to the applicable regulations/ circulars/directions specified by SEBI from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

General disclosures: PrimeInvestor Financial Research Pvt Ltd (with brand name PrimeInvestor) is an independent research entity offering research services on personal finance products to customers. We are a SEBI registered Research Analyst (Registration: INH200008653). PrimeInvestor Financial Research Pvt. Ltd., its employees, directors or agents, do not have any material adverse disciplinary history as on the date of publication of this report.

Restrictions on trading: To ensure no conflict of interest, the RA declares as follows:

  1. Personal trading activities of the individuals employed as research analysts shall be monitored, recorded and subject to a formal approval by the directors or compliance officer of PrimeInvestor Financial Research Private Limited.
  2. Research analysts employed by PrimeInvestor Financial Research Private Limited or their associates or relatives shall not:
    • Deal/ trade in stocks recommended/ tracked by the research analyst within 30 days before and five days after the publication of a research report;
    • Deal/ trade in securities that the research analyst reviews in a manner contrary to the given recommendation;
    • Purchase or receive securities of the issuer before the issuer's initial public offering, if the issuer is principally engaged in the same types of business as companies that the research analyst follows or recommends.

Disclosures with respect to Research and Recommendations Services:

  1. The RA or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation.
  2. The RA, or any of its officers, directors, employees, or subsidiaries have not received any compensation/ benefits whether monetary or in kind, from the AMC, company, government, bank or any other product manufacturer or third party, whose products are the subject of its Research Services or investment information.
  3. The Research Analysts who have prepared the research reports that form part of the Research Services (“Research Analyst”) certify that all of the views expressed in the research report accurately reflect their views about the subject company or subject security.
  4. The RA or directors or employees or Research Analyst certify that no part of their compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report.
  5. The Research Analyst has not served as director, officer or employee in the subject company, AMC or insurance company of the mutual fund or insurance policy that is the subject of this report, or company whose bonds, NCDs, fixed deposits or other savings products that is the subject of this report.
  6. The Research Analyst or their relatives do not have any known direct or indirect material conflict of interest including long/short positions in the subject company.
  7. The Research Analyst may hold investments in the stocks, mutual fund schemes, bonds, fixed deposits, insurance policies, or other products that are the subject of the recommendations provided as part of the Research Services. The Research Analyst certifies that they will not act in a manner contrary to their views on these securities except in the event of significant news or event or change in personal financial circumstances and without formal approval from the directors of PrimeInvestor Financial Research Pvt. Ltd. or the compliance officer.
  8. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of the Research Services. Such conflict of interest shall be disclosed to the client as and when they arise.
  9. The RA or its directors or its employee or its associates have not managed or co-managed the public offering of any company. The RA or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. The RA or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. The RA or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation.
  10. The subject company of its research recommendations was not a client of the RA or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided.
  11. The RA or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.

PrimeInvestor Financial Research Pvt. Ltd., its Associates, the Research Analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies)? – NO

8. Termination of service and refund of fees:

The RA may terminate or suspend rendering of Research Services to the client in the following circumstances:

  1. On account of suspension/cancellation of registration of RA by SEBI. In case of suspension of certificate of registration of the RA for more than 60 (sixty) days or cancellation of the RA registration, RA shall refund the fees, on a pro rata basis for the period from the effective date of cancellation/ suspension to end of the client’s subscription period.
  2. The RA voluntarily chooses to terminate its Research Service. In the event of such termination of the Research Service, the RA shall refund the fees, on a pro rata basis for the period from the date of such termination of research service to end of the client’s subscription period.

9. Grievance redressal and dispute resolution:

Any grievance related to:

  1. nonreceipt of research report, or
  2. missing pages or inability to download the entire report, or
  3. any other deficiency in the research services provided by RA

shall be escalated promptly by the client to the person/employee designated by RA, in this behalf as under:

Name: Bhavana Acharya
Designation: Director & Compliance Officer, PrimeInvestor Financial Research Pvt Ltd
Email: [email protected]

The RA shall be responsible to resolve grievances within 7 (seven) business working days or such timelines as may be specified by SEBI under the RA Regulations.

RA shall redress grievances of the client in a timely and transparent manner. Any dispute between the RA and his client may be resolved through arbitration or through any other modes or mechanism as specified by SEBI from time to time.

If the client is not satisfied with the response of the RA, he/she can lodge his/her grievances with SEBI at scores.sebi.gov.in. Alternatively, the client may also write to any of the offices of SEBI. For any queries, feedback or assistance, please contact SEBI Office on Toll Free Helpline at 1800 22 7575 / 1800 266 7575

Details on grievances are available on the Website as follows: https://primeinvestor.in/ra-grievance/

10. Additional clauses:

Scope of the Research Service: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Services are not meant to be tailor-made or customized solutions that specifically apply to each client based on his/her risk profile.

The RA never guarantees the returns on the recommendation provided. Investor shall take note that investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The RA shall not be responsible for any loss to the Investors.

This service is not directed for access or use by anyone in a country, especially the USA, Canada or the European Union countries, where such use or access is unlawful or which may subject PrimeInvestor Financial Research Pvt Ltd or its affiliates to any registration or licensing requirement.

The Research Service, including recommendations, research reports, updates, and other information will be accessible through the RA’s website https://primeinvestor.in only. Such recommendations and updates will not be provided over phone calls.

Fees: Our current fee structure, the term and duration of our subscription for our Research Service, can be viewed on our website: https://primeinvestor.in/prime-pricing. Eligibility for any discounts is ascertained at the time the client subscribes. Any such discount and its tenure shall be at the discretion of the RA.

Subscription and access to content services fall under the purview of Goods and Services Tax (GST) as per the current indirect taxation policy, Government of India. Unless otherwise indicated, prices stated on our website are exclusive of applicable GST, any applicable value added tax (VAT) or other sales taxes. We are a business-to-consumer (B2C) service provider and we do not commit to provide any input tax credit on GST charged on subscription to our Research Service.

We may change the Subscription Fees and charges then in effect, or add new fees or charges which will take effect at the end of the client’s subscription period, by giving notice in advance and an opportunity to cancel renewal of the subscription.

Subscription Access & Renewal: Subscription to the Website commences immediately on the realisation of payment of the Subscription Fees. Subscriptions are set to be renewed automatically at the end of the subscription period.

Unless the client notifies us before the end of his/her subscription period, or the client cancels the auto-renewal mandate within the period specified by law, that the client does not wish to renew his/her subscription, the client’s subscription will renew for the period defined by the client’s subscription plan. We will charge the subscription using the same payment method that you previously used.

Although the client may notify to us his/her intention to his/her subscription, such notice will only take effect at the end of his/her then current subscription period, and he/she will not receive a refund other than as set out under Clause 8 in these Terms.

The client may notify us of his/her wish to cancel his/her subscription by sending an email to [email protected]. The client must provide at least 5 business days advance notice for this to be implemented.

Refunds: There can be no cancellation and refund of subscription fee paid once the subscription is active, other than as stated in Clause 8 of these Terms. If the client is entitled to a refund as specified under Clause 8 of these Terms, the RA will credit that refund to the card or other payment method used by the client to submit payment, unless it has expired - in which case the RA will contact the client to proceed with the refund. If we do issue a refund or credit due to circumstances outside the obligations specified under Clause 8, we are under no obligation to issue the same or a similar refund in the future.

General disclaimers: The recommendations made herein in the Research Services are expression of views and/or opinions and should not be deemed or construed to be advice for the purpose of purchase or sale of any security, nor a solicitation or offering on any investment/ trading opportunity on behalf of the company, AMC, insurance company, or issuer of security referred to herein.

The content and research reports generated by the RA does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities.

The information/ opinion/ views mentioned in research reports or by the RA are not meant to serve as a professional guide to the client or recipients of this Report. The research report, recommendation, or any other content published by the RA do not assure or guarantee any minimum or fixed returns to the client or recipients of the reports/ recommendations/ content.

Use of this information is at the client’s own risk. The client must make his/ her own investment decisions based on his/her specific investment objective and financial position and using such independent advisors as he/she believes necessary. The services rendered by the RA are on a best-effort basis. All information in the content or research report of the RA is provided on an as is basis. Information is believed to be reliable but the RA does not warrant its completeness or accuracy and expressly disclaim all warranties and conditions of any kind, whether express or implied.

While due care has been taken to ensure that the disclosures, information, and opinions given are fair and reasonable, PrimeInvestor Financial Research Pvt Ltd and/or none of its officers, directors, partners, employees, agents, subsidiaries, affiliates or business associates shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information/ opinions/ views contained in the research report and recommendations that form part of the Research Service, and/or mails, social media or notifications issued by PrimeInvestor Financial Research Pvt Ltd or any other agency appointed/authorised by PrimeInvestor Financial Research Pvt Ltd. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

Any agreements, transactions or other arrangements made between the client and any third party named on (or linked to from) the Website are at your own responsibility and entered into at your own risk. Any information that you receive via the Website, whether or not it is classified as “real time”, may have stopped being current by the time it reaches you. Market price information may be rounded up/down and therefore may not be entirely accurate.

The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research Services before onboarding.

History, present business and background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services.

Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made thereunder against the Research Analyst relating to Research Analyst services.

Details of the RA's associates: No associates.

Usage of Website Content: This Website is controlled and operated by the RA. All material, including research reports, recommendations, portfolios, ratings, lists of financial products, illustrations, statements, opinions, views, photographs, products, images, artwork, designs, text, graphics, logos, button icons, images, audio and video clips and software (collectively, “Content”) are protected by copyrights, trademarks and other intellectual property rights that are owned and controlled by the RA or by other parties that have licensed their material to us.

Except where otherwise agreed in writing with the RA, material on the Website is solely for the client’s personal, non-commercial use. Except as provided below, the client must not copy, reproduce, republish, upload, post, transmit or distribute such material in any way, including by e-mail or other electronic means and whether directly or indirectly and the client must not assist any other person to do so.

Without the prior written consent of the RA, modification of the materials, use of the materials on any other web site or networked computer environment or use of the materials for any purpose other than personal, non-commercial use is a violation of the copyrights, trademarks and other proprietary rights, and is prohibited. Any use for which the client receives any remuneration, whether in money or otherwise, is a commercial use for the purposes of these Terms.

The client may occasionally distribute a copy of a research report, or a portion of the same, from the Website in non-electronic form to a few individuals without charge, provided the client includes all copyright and other proprietary rights notices in the same form in which the notices appear, original source attribution, and the phrase “Used with permission from PrimeInvestor Financial Research Pvt. Ltd.”

While the client may occasionally download and store research reports or information from the Website for his/her personal use, he/she may not otherwise provide others with access to the same. The foregoing does not apply to any sharing functionality we provide through the Website that expressly allows the client to share Content or links to Content with others. In addition, the client may not use Content he/she has downloaded for personal use to develop or operate an automated trading system or for data or text mining.

The client agrees not to rearrange or modify the Content available through the Website. The client agrees not to display, post, frame, or scrape the Content for use on another website, app, blog, product or service, except as otherwise expressly permitted by these Terms. You agree not to create any derivative work based on or containing the research products and Content. The framing or scraping of or in-line linking to the Services or any Content contained thereon and/or the use of webcrawler, spidering or other automated means to access, copy, index, process and/or store any Content made available on or through the Services other than as expressly authorized by us is prohibited.

The client further agrees to abide by exclusionary protocols (e.g., Robots.txt, Automated Content Access Protocol (ACAP), etc.) that may be used in connection with the Research Services. The client may not access parts of the Research Services to which he/she is not authorized, or attempt to circumvent any restrictions imposed on your use or access of the Services.

As a general rule, the client may not use the Content, including without limitation, any Content made available through one of our RSS Feeds, in any commercial product or service, without our express written consent.

The client may not create apps, extensions, or other products and services that use our Content without our permission. The client may not aggregate or otherwise use our Content in a manner that could reasonably serve as a substitute for a subscription to the Website.

The client may not access or view the Services with the use of any scripts, extensions, or programs that alter the way the Services are displayed, rendered, or transmitted to you without our written consent.

The client agrees not to use the Services for any unlawful purpose. We reserve the right to terminate or restrict the client's access to the Website if, in our opinion, the client's use of the Services may violate any laws, regulations or rulings, infringe upon another person's rights or violate these Terms.

Prohibited content: The Website includes comments sections, blogs and other interactive features that allow interaction among clients and between clients and the RA. We call the information posted by or contributed by users “Contributed Content.” In the course of availing of the Research Services or uploading any post or comment on the Website, the client shall not post any Contributed Content that (i) contains nude, semi-nude, sexually suggestive photos, (ii) tends or is likely to abuse, harass, threaten, impersonate or intimidate other users of the Website and/or Research Services, (iii) is lascivious or appeals to the prurient interest or if its effect is such as to tend to deprave and corrupt persons who are likely to use or have access to the Website and/or Services, or (iv) otherwise violates, is prohibited or restricted by applicable law, rule or regulation, is offensive or illegal or violates the rights of, harms or threatens the safety of other users of the Website and/or Services (collectively “Prohibited Content”).

We reserve the right to cease to provide the client with the Research Services or access to the Website, or terminate your subscription, with immediate effect and without notice and liability, for violating these Terms, applicable law, rules or regulations and reserves the right to remove Prohibited Content which is in violation of these Terms, or is otherwise abusive, illegal or disruptive. The determination of whether any content constitutes Prohibited Content, violates these Terms, or is otherwise abusive illegal or disruptive, is subject to the sole determination of the Firm.

Changes to Research Services: We are constantly endeavouring to improve the quality of Research Services provided to our clients. Due to this, the form and nature of the Research Services provided may change from time to time without any prior notice to the client. We reserve the right to introduce and initiate new features, functionalities, components to the Website and/or Research Services and/or change, alter, modify, or discontinue existing ones without any prior notice to the client.

Warranty and liability disclaimer: The Website, Research Services, and all the materials and services, included on or otherwise made available to the client through this Website is provided by the RA on an “as is” and “as available” basis without any representation or warranties, express or implied except otherwise specified in writing. Without prejudice to the foregoing paragraph, the RA does not warrant that:

  • This Website and/or Research Services will be constantly available, or available at all;
  • The information on this Website or provided through the Research Services is complete, true, accurate or not misleading; or
  • The quality of any products, services, information, or other material that you obtain through the Website or Services will meet your expectations.

The RA, to the fullest extent permitted by law, disclaims all warranties, whether express or implied, including the warranty of merchantability, fitness for particular purpose and non-infringement. The RA makes no warranties about the accuracy, reliability, completeness, or timeliness of the Website, Research Services, Content, Contributed Content, Services, software, text, graphics and links.

The RA does not warrant that this Website, Research Services, information, content, materials, or any other material included on or otherwise made available to you through this Website, their servers, or electronic communication sent by the RA are free of viruses or other harmful components.

Nothing on this Website constitutes, or is meant to constitute, advice of any kind.

Indemnification: The client:

  1. Represents, warrants and covenants that no materials of any kind provided by him/her will:
    1. Violate, plagiarise, or infringe upon the rights of any third party, including copyright, trademark, privacy or other personal or proprietary rights; or
    2. Contain libellous, Prohibited Content or other unlawful material;
  2. Hereby agree to indemnify, defend and hold harmless the RA and all of the RA’s officers, directors, owners, agents, customers/clients, information providers, affiliates, licensors and licensees (collectively, the “Indemnified Parties”) from and against any and all liability and costs, including, without limitation, reasonable advocate’s fees, incurred by the Indemnified Parties in connection with any claim arising out of any breach by the client of these Terms or the foregoing representations, warranties and covenants. The client shall cooperate as fully as reasonably required in the defence of any such claim. The RA reserves the right, at its own expense, to assume the exclusive defence and control of any matter subject to indemnification by the client.

Applicable law: This Website, including the Content and Contributed Content and information contained herein, and the provision of Research Services shall be governed by the Securities and Exchange Board of India, laws of the Republic of India and the courts of Chennai, India which shall retain exclusive jurisdiction to entertain any proceedings in relation to any disputes arising out of the same. As such, the laws of India shall govern any transaction completed using this Website.

Information gathered and tracked: Information submitted or collected on the Website or pursuant to the use of the Services is stored in a database. Specifically, we store the username, name, e-mail address, contact number, as submitted or collected on our Website or through the provision of the Research Services. We may use such information to send out occasional promotional materials, including alerts on new Services available, or other promotional and marketing material relating to our clients and customers.

In accordance with the Information Technology Act 2000, the name and the details of the Grievance Officer at PrimeInvestor is provided below:

Mr. Srikanth Meenakshi
PrimeInvestor Financial Research Pvt. Ltd., Registered office: 659, 4th Avenue, D-Sector, Anna Nagar Western Extension, Chennai 600 101.
Email: [email protected]

11. Mandatory notice:

Clients shall be requested to go through Do’s and Don’ts while dealing with RA as specified in SEBI master circular no. SEBI/HO/MIRSD-POD-1/P/CIR/2024/49 dated May 21, 2024 or as may be specified by SEBI from time to time.

12. Optional Centralised Fee Collection Mechanism:

SEBI has operationalized a centralized fee collection mechanism for IA and RA. Under this mechanism, clients shall pay fees to IAs/RAs through a designated platform/portal administered by a recognized Administration and Supervision body. This is an optional mechanism for the registered entities. At this time, PrimeInvestor has opted out of this fee collection mechanism. Therefore, all subscription payments for the Research Services will be through the modes as specified in Clause 5 of these Terms.

Enter the OTP sent to (Edit)
By doing this you agree to our terms & conditions
Didn't receive OTP? Resend

Have an account?
Login To Your Account
OR
Don’t have an account ? Register for free